[1]
Schrage B,Ibrahim K,Loehn T,Werner N,Sinning JM,Pappalardo F,Pieri M,Skurk C,Lauten A,Landmesser U,Westenfeld R,Horn P,Pauschinger M,Eckner D,Twerenbold R,Nordbeck P,Salinger T,Abel P,Empen K,Busch MC,Felix SB,Sieweke JT,Møller JE,Pareek N,Hill J,MacCarthy P,Bergmann MW,Henriques JPS,Möbius-Winkler S,Schulze PC,Ouarrak T,Zeymer U,Schneider S,Blankenberg S,Thiele H,Schäfer A,Westermann D, Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock. Circulation. 2019 Mar 5; [PubMed PMID: 30586755]
[2]
Basra SS,Loyalka P,Kar B, Current status of percutaneous ventricular assist devices for cardiogenic shock. Current opinion in cardiology. 2011 Nov; [PubMed PMID: 21926617]
[3]
Naidu SS, Novel percutaneous cardiac assist devices: the science of and indications for hemodynamic support. Circulation. 2011 Feb 8; [PubMed PMID: 21300961]
[4]
Rihal CS,Naidu SS,Givertz MM,Szeto WY,Burke JA,Kapur NK,Kern M,Garratt KN,Goldstein JA,Dimas V,Tu T, 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d'intervention. Journal of the American College of Cardiology. 2015 May 19; [PubMed PMID: 25861963]
[5]
Glazier JJ,Kaki A, The Impella Device: Historical Background, Clinical Applications and Future Directions. The International journal of angiology : official publication of the International College of Angiology, Inc. 2019 Jun; [PubMed PMID: 31384109]
[6]
Anderson MB,Goldstein J,Milano C,Morris LD,Kormos RL,Bhama J,Kapur NK,Bansal A,Garcia J,Baker JN,Silvestry S,Holman WL,Douglas PS,O'Neill W, Benefits of a novel percutaneous ventricular assist device for right heart failure: The prospective RECOVER RIGHT study of the Impella RP device. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2015 Dec; [PubMed PMID: 26681124]
[7]
Pieri M,Pappalardo F, Impella RP in the Treatment of Right Ventricular Failure: What We Know and Where We Go. Journal of cardiothoracic and vascular anesthesia. 2018 Oct; [PubMed PMID: 30093192]
[8]
Martinez CA,Singh V,Heldman AW,O'Neill WW, Emergent use of retrograde left ventricular support in patients after transcatheter aortic valve replacement. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography [PubMed PMID: 22888042]
[9]
Miller MA,Dukkipati SR,Chinitz JS,Koruth JS,Mittnacht AJ,Napolitano C,d'Avila A,Reddy VY, Percutaneous hemodynamic support with Impella 2.5 during scar-related ventricular tachycardia ablation (PERMIT 1). Circulation. Arrhythmia and electrophysiology. 2013 Feb; [PubMed PMID: 23255277]
[10]
Lemaire A,Anderson MB,Lee LY,Scholz P,Prendergast T,Goodman A,Lozano AM,Spotnitz A,Batsides G, The Impella device for acute mechanical circulatory support in patients in cardiogenic shock. The Annals of thoracic surgery. 2014 Jan; [PubMed PMID: 24090575]
[11]
Lauten A,Engström AE,Jung C,Empen K,Erne P,Cook S,Windecker S,Bergmann MW,Klingenberg R,Lüscher TF,Haude M,Rulands D,Butter C,Ullman B,Hellgren L,Modena MG,Pedrazzini G,Henriques JP,Figulla HR,Ferrari M, Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry. Circulation. Heart failure. 2013 Jan; [PubMed PMID: 23212552]
[12]
Seyfarth M,Sibbing D,Bauer I,Fröhlich G,Bott-Flügel L,Byrne R,Dirschinger J,Kastrati A,Schömig A, A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. Journal of the American College of Cardiology. 2008 Nov 4; [PubMed PMID: 19007597]
[13]
O'Neill WW,Kleiman NS,Moses J,Henriques JP,Dixon S,Massaro J,Palacios I,Maini B,Mulukutla S,Dzavík V,Popma J,Douglas PS,Ohman M, A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation. 2012 Oct 2; [PubMed PMID: 22935569]
[14]
Kapur NK,Esposito ML,Bader Y,Morine KJ,Kiernan MS,Pham DT,Burkhoff D, Mechanical Circulatory Support Devices for Acute Right Ventricular Failure. Circulation. 2017 Jul 18; [PubMed PMID: 28716832]
[15]
Doll JA,Ohman EM,Patel MR,Milano CA,Rogers JG,Wohns DH,Kapur NK,Rao SV, A team-based approach to patients in cardiogenic shock. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography [PubMed PMID: 26526563]
[16]
Tehrani BN,Truesdell AG,Sherwood MW,Desai S,Tran HA,Epps KC,Singh R,Psotka M,Shah P,Cooper LB,Rosner C,Raja A,Barnett SD,Saulino P,deFilippi CR,Gurbel PA,Murphy CE,O'Connor CM, Standardized Team-Based Care for Cardiogenic Shock. Journal of the American College of Cardiology. 2019 Apr 9; [PubMed PMID: 30947919]